IP Library › Granted Patent US 11,751,775
Granted Patent B2
US 11,751,775 · App. 16/999,597 · Granted Sep 12, 2023

Electrical device for monitoring, prevention, and treatment of implant infections

Inventor: David Armbruster (West Chester, PA)
Assignee: DePuy Synthes Products, Inc.
A61B5/053A61B5/0002A61B5/746A61B17/64G16H50/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,751,775
App. No.
16/999,597
Granted
Sep 12, 2023
Kind
B2
Abstract

A device, having a housing; a power source configured to supply electrical power to a conductive percutaneous implant in a circuit including the conductive percutaneous implant and tissue of a patient adjacent to the conductive percutaneous implant; an electrical sensor configured to generate a signal indicative of at least one electrical parameter of the circuit; and at least one data processing system having one or more processors configured to receive the signal and analyze the signal to determine at least one of a presence or change of infection of the tissue, and pass a control signal to the power source to vary the electrical power responsive to determining at least one of the presence or change of infection of the tissue.

Claims (28)

1. A device, comprising:

a housing;

a power source configured to supply electrical power to a conductive percutaneous implant in a circuit including the conductive percutaneous implant and tissue of a patient adjacent to the conductive percutaneous implant;

an electrical sensor configured to generate a signal indicative of at least one electrical parameter of the circuit; and

at least one data processing system having one or more processors configured to receive the signal and analyze the signal to determine at least one of a presence or change of infection of the tissue, and pass a control signal to the power source to vary the electrical power responsive to determining at least one of the presence or change of infection of the tissue.

2. The device of claim 1 , wherein the housing is configured to be worn by the patient.

3. The device of claim 1 , wherein the electrical sensor monitors resistance within the circuit.

4. The device of claim 1 , wherein the power source includes a reference electrode configured to be placed upon a skin of the patient.

5. The device of claim 1 , wherein the power source is connected to an implant connector sized and dimensioned to be connected to the conductive percutaneous implant, the implant connector having a body, a first electrode, and a second electrode, the body supporting the first electrode and the second electrode, the first electrode positioned to engage the conductive percutaneous implant, and the second electrode positioned to engage a skin of the patient, the first electrode being electrically isolated from the second electrode.

6. The device of claim 1 , wherein the power source includes a reference electrode configured to be within the circuit, the reference electrode having an implant connector configured to be connected to a second conductive percutaneous implant.

7. The device of claim 1 , further comprising a wireless communication device, and wherein the one or more processors is configured to provide an alert to the wireless communication device and enable the wireless communication device to transmit the alert based upon the control signal.

8. The device of claim 1 , wherein analyzing the signal includes supplying the signal to an artificial intelligence network trained with a percutaneous implant data model to determine at least one of the presence or change of infection of the tissue.

9. The device of claim 1 , wherein analyzing the signal includes comparing the signal to a stored infection parameter to determine at least one of the presence or change of infection of the tissue.

10. The device of claim 1 , wherein varying the electrical power includes increasing or decreasing an amount of the electrical power.

11. A wearable device, comprising:

a housing configured to be worn by a patient;

a first power source configured to supply first electrical power to a conductive percutaneous implant in a circuit including the conductive percutaneous implant and a tissue adjacent to the conductive percutaneous implant,

an electrical sensor configured to generate a signal indicative of at least one electrical parameter of the circuit; and

at least one data processing system having one or more processors configured to receive the signal and analyze the signal to determine an infection status of the tissue, the infection status determined to be infected, not infected, or some changed amount of infection as compared to a prior infection state baseline and pass a control signal to the power source to vary the electrical power responsive to the infection status of the tissue being infected.

12. The wearable device of claim 11 , wherein the housing has a band configured to be worn by the patient.

13. The wearable device of claim 11 , wherein the electrical sensor monitors resistance within the circuit.

14. The wearable device of claim 11 , wherein the power source includes a reference electrode configured to be placed upon a skin of the patient.

15. The wearable device of claim 11 , wherein the power source is connected to an implant connector sized and dimensioned to be connected to the conductive percutaneous implant, the implant connector having a body, a first electrode, and a second electrode, the body supporting the first electrode and the second electrode, the first electrode positioned to engage the conductive percutaneous implant, and the second electrode positioned to engage a skin of the patient, the first electrode being electrically isolated from the second electrode.

16. The wearable device of claim 11 , and wherein the power source includes a reference electrode configured to be within the circuit, the reference electrode having an implant connector configured to be connected to a second conductive percutaneous implant.

17. The wearable device of claim 11 , further comprising a wireless communication device, and wherein the one or more processors is configured to provide an alert to the wireless communication device and enable the wireless communication device to transmit the alert responsive to the infection status of the tissue determined to be infected.

18. The wearable device of claim 11 , wherein analyzing the signal includes supplying the signal to an artificial intelligence network trained with a percutaneous implant data model to determine the infection status of the tissue.

19. The wearable device of claim 11 , wherein analyzing the signal includes comparing the signal to a stored infection parameter to determine the infection status of the tissue.

20. The wearable device of claim 11 , wherein varying the electrical power includes increasing an amount of the electrical power.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 17, 2020
From: ARMBRUSTER, DAVID
To: SYNTHES USA PRODUCTS, LLC.
Reel/Frame 053801/0573 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 17, 2020
From: SYNTHES USA PRODUCTS, LLC.
To: DEPUY SYNTHES PRODUCTS, INC.
Reel/Frame 053801/0673 →
Continuity (2)
Provisional Application 62894311 · Aug 30, 2019
Related Publication 20210059554A1 · Mar 4, 2021